EditorialPresident Donald Trump with, from left, Vice President Mike Pence, Daniel O'Day, CEO of Gilead, and Stephen Hahn, FDA commissioner, in the Oval Office at the White House in Washington, May 1, 2020. (Erin Schaff/The New York Times)
EditorialDaniel O'Day, the chief executive of Gilead Sciences, the manufacturer of remdesivir, stands in-between Vice President Mike Pence and President Donald Trump, as he speaks in the Oval Office of the White House in Washington, May 1, 2020. (Erin Schaff/The New York Times)
EditorialVice President Mike Pence, and Daniel O'Day, the CEO of Gilead, in the Oval Office of the White House while meeting with President Donald Trump in Washington, Friday, May 1, 2020. (Erin Schaff/The New York Times)